CDC2024EN

CDC PrEP Clinical Practice Guideline

Zusammenfassung

CDC CLINICAL GUIDELINE TITLE: CDC PrEP Clinical Practice Guideline SOURCE: Centers for Disease Control and Prevention (CDC) PUBLICATION YEAR: 2024 URL: https://www.cdc.gov/hivnexus/hcp/prep/index.html LICENSE: Public Domain (US Federal Government) SPECIALTIES: infectious_disease, primary_care GUIDELINE CONTENT: • • • • • • • Clinical Guidance for PrEP | HIV Nexus | CDC • Skip directly to site content Skip directly to search An official website of the United States government

Kerninformationen

Whether or not a patient asks for PrEP, it is important to take a sexual and substance use history. This information is essential to understanding each patient's chances of getting HIV, if PrEP might be right for them, and what other risk-reduction services they might need. Use the following flowcha...
Since PrEP is indicated for people with risk factors for HIV, acute HIV infection should be suspected in patients who were recently exposed. Ask all PrEP candidates with a negative or indeterminate HIV test result about whether they have experienced any signs or symptoms of viral infection in the pa...
However, in people with active HBV, stopping these medicines can result in a rebound of HBV replication leading to liver damage. HBV infection is not a contraindication to PrEP, but all people considered for oral PrEP with F/TDF or F/TAF must be screened for HBV. Patients with active HBV infection s...
Originaldokument ansehen

Fragen zu diesem Thema?

ClariMed durchsucht alle Leitlinien mit KI und liefert quellenbasierte Antworten in Sekunden.

Jetzt auf ClariMed suchen

Verwandte Leitlinien